
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. (DICE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DICE · as of Jun 9, 2026
Key Statistics
Explore DICE Therapeutics, Inc. Data
dice stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 50.0%
The DICE analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $60.00, representing +26.18% upside from the current price of $47.55.
Competitors & Peers
dice competitorsStock Performance
Full HistoryAbout DICE Therapeutics, Inc.
DICE Therapeutics, Inc. is a biopharmaceutical firm focused on creating innovative oral drug candidates to address chronic immunological disorders and other medical conditions. The company leverages i…
what is dice therapeutics, inc. · dice stock overview · dice therapeutics, inc. company profile · who is dice therapeutics, inc. ceo · dice NASDAQ · dice therapeutics, inc. headquarters · dice therapeutics, inc. business segments
About Stock Overview & Key Data
DICE Therapeutics, Inc. (DICE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2021. As of the latest trading session, DICE stock price is $47.55, with a market capitalization of $2.3B. The stock has returned +126.21% over the past 12 months and +51.77% year-to-date.
According to 10 Wall Street analysts, the consensus rating for DICE Therapeutics, Inc. stock is Buy, with an average 12-month price target of $60.00. In fiscal year 2022, DICE Therapeutics, Inc. reported revenue of — and net income of -$81.7M. For detailed data — including DICE Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DICE Therapeutics, Inc. (DICE) stock price is $47.55. The stock is traded on NASDAQ under the ticker symbol DICE. The 52-week range is $15.08 – $47.90.